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1. Introduction 
In most mammalian cells, guanylate cyclase 
activity is found in both soluble and particulate frac- 
tions. Stimulation by Triton X-100 of both types of 
guanylate cyclase is well known [1]. In rat small 
intestines guanylate cyclase is stimulated and adenylate 
cyclase inhibited by the same concentration fTriton 
X-100 [2]. Lysolecithin, which is a widely distributed 
and naturally occurring detergent [3], and has been 
shown to induce cell fusion [4] is known to stimulate 
membrane-associated syalyltransferase [5] and 
galactosyltransferase activities [6] in a manner similar 
to Triton X-100. Guanylate cyclase in rat lung is 
stimulated by lysolecithin and phospholipase A [7]. 
In the other hand, Fujimoto and Okabayashi [8] 
have reported that guanylate cyclase in guinea pig 
tracheal muscle homogenate is stimulated by phos- 
pholipase A. Studies on cultured neuroblastoma cells 
have contributed evidence indicating arole for cyclic 
nucleotides in the regulation of cell differentiation 
[9-10]. Thus it can be expected that either lyso- 
lecithin or phospholipase A (producing lysolecithin) 
play a regulatory role in cell differentiation. 
We have observed that lysolecithin stimulates 
neuroblastoma cells homogenate guanylate cyclase up 
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to 11-fold. Membrane-bound as well as soluble 
guanylate cyclase is stimulated. Simultaneously 
adenylate cyclase is inhibited by the same concentra- 
tion of lysolecithin. Phospholipase A also induces a
doubling uanylate cyclase activity. 
2. Materials and methods 
In this study an adrenergic neuroblastoma clone, M1 
[11] was used. Cells were grown to confluency in 
Falcon plastic dishes (75 cm 2) in Dulbecco's modified 
Eagle's medium, supplemented with 10% foetal calf 
serum. Cultres were maintained at 37°C in a humidified 
atmosphere of 5% CO2 in air. Cultures were harvested 
during confluence in Tris-HC1 buffer (10 mM, pH 7.5). 
Guanylate cyclase activity was determined on 
aliquots containing 80-180/ag protein by the method 
of Goridis and Reutter [12]. 3-Isobutyl-l-methyl- 
xanthine was used as phosphodiesterase inhibitor. 
Adenylate cyclase activity was determined essentially 
by the method of Ramachandran d Lee [13]; 
0.5 mM ATP as substrate was used. Cyclic nucleotide 
phosphodiesterase ctivity was letermined following 
the two steps isotopic procedure as described by Coquil 
et al. [14] ; 10/aM each cyclic nucleotide was used as 
substrate. Protein was determined by the method of 
Lowry et al. [15]. 
For lysolecithin treatment, cell homogenate was 
preincubated with the indicated amount of lysolecithin 
(Egg Yolk-Sigma). The alcoholic solution of the phos- 
pholipid was brought o dryness under a stream of N2 
before adding cell homogenate. After 10 min preincuba- 
tion at 0°C, the mixture was diluted three times with 
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Tris-HC1 buffer (10 mM, pH 7.5). An aliquot of 
40/al was taken for immediate determination of 
enzyme activities. A similar procedure is used for 
testing other phospholipids. Triton X-100 (1%) was 
also used during 10 min preincubation at 0°C. 
For phospholipase treatment, cell homogenate was 
incubated with phospholipase A (Crotalus venom- 
Boehringer),in a medium containing 50 mM Tris-HC1 
(pH 7.5) and 1 mM CaCI: at 37°C for 7 min. After 
incubation and dilution of the mixture, guanylate 
cyclase activity was immediately assayed. 
3. Results 
As shown in table I, lysolecithin stimulate 
guanylate cyclase activity in homogenate of M1 
neuroblasts 11-fold. The effect appeared specific 
since neither phosphatidylcholine or lysophospha- 
tidylethanolamine or phosphatidylethanolamine 
produce a stimuation of guanylate cyclase. The effect 
was at a maximum after 6 min of  preincubation at 0°C 
(fig.l). It was dose-dependent up to 2 mg/ml lyso- 
lecithin during the preincubation (fig.2). At a higher 
dosage, the stimulation effect decreased. At the maxi- 
mum response of guanylate cyclase, adenylate cyclase 
was almost completely inhibited (fig.2). Lysophospha- 
tidylethanolamine was also without effect on adenylate 
cyclase activity as shown in table 2. Triton X-100 (1%) 
had a similar effect on adenylate cyclase activity as 
lysolecithin, when homogenate was tested (table 2). 
Table 1 
Effect of several phospholipids on guanylate cyclase activity 
(pmoles cGMP formed/min/ 
mg prot.) +- S.D. 
Control 2.87 +- 0.38 
Lysolecithin 32.0 -+ 2.8 
Lecithin 2.80 -+ 0.10 
Lysophosphatidyl- 
ethanolamine 2.86 -+ 0.31 
Phosphatidyl- 
ethanolamine 2.84 -+ 0.32 
Aliquots of M1 cells homogenate were preincubated with each 
phospholipid (2 mg/ml) as described in Methods. The mean 
-+ S.D. of 4 determinations is given. 
Time (mini 
Fig.1. Time-course of guanylate cyclase stimulation by lyso- 
lecithin (2 mg/ml during the preincubation) in neuroblastoma 
M1 cells. Guanylate cyclase specific activity is expressed as 
pmoles/min/mg protein. Each point is the mean of at least 
3 determinations. Standard eviation is less than 13%. 
Cyclic GMP phosphodiesterase activity remained 
unchanged with each of both treatment while cAMP 
phosphodiesterase was slightly stimulated (36%) when 
treated with lysolecithin but not with Triton (table 3). 
.% 
Fig.2. Dose-response curves of stimulation of guanylate 
cyclase (e o) and of inhibition of adenylate cyclase 
(o . . . .  o) by lysolecithin. Concentrations of lysolecithin 
indicated are those present in 10 min preincubation. Specific 
activities are expressed as pmoles/min/mg protein. The mean 
value is given for 4 determinations. Standard eviation is less 
than 11% for guanylate cyclase and 21% for adenylate cyclase 
activity. 
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Table 2 
Effect of several detergents on adenylate cyclase 
specific activity 
(pmoles cAMP formed/min/ 
mg protein) 
Control 2.38 • 0.18 
Lysolecithin (2 mg/ml) 0.65 ± 0.21 
Triton X-100 (1%) 0.55 ± 0.15 
Lysophosphatidyl- 
ethanolamine (2 mg/ml) 1.80 ± 0.35 
Concentrations of detergents indicated were present during 
preincubation (10 min; 0°C). Each value is the mean ± S.D. 
of 4 determinations. 
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When M1 cells were treated in parallel with lyso- 
lecithin and with Triton, and then centrifuged 
(100 000 × g, 1 h), 47% of  the guanylate cyclase 
activity was found in the soluble fraction with the 
former treatment, while 91% of  the activity was 
solubilysed with the latter treatment (table 4). 
However, Tr i tonas well as lysolecithin stimulation of 
the homogenate guanylate cyclase were similar. In the 
particulate fraction of  lysolecithin treated cells, the 
specific activity of  guanylate cyclase was lower. 
In order to characterize the effect of  lysolecithin, 
the apparent K m and V were measured. It appears that 
under the effect of  lysolecithin, there is a decrease of  
the apparent K m and a doubling of V (table 5). 
Table 3 
Effect of lysolecithin and Triton X-100 on cyclic nucleotide 
phosphodiesterase ctivity 
cGMP cAMP 
phosphodiesterase phosphodiesterase 
(nmoles/min/mg prot.) (nmoles/min/mg prot.) 
Control 1.84 ± 0.26 0.42 ± 0.06 
Ly solecithin 
(2 mg/ml) 1.74 -+ 0.14 0.57 ± 0.05 
Triton X-100 (1%) 1.80 ± 0.15 0.36 ± 0.08 
Enzymatic activity was measured with respectively 10/aM each cyclic nucleotide 
as substrate. Each value represents he mean ± S.'D. of 3 to 5 determinations. 
Table 4 
Effect of lysolecithin and Triton X-100 on the sedimentation f 
guanylate cyclase at 100 000 g 
Treatment Percent of total Guanylate cyclase specific 
enzyme activity activity 
in the soluble 
fraction Homogenate Soluble Particulate 
Control 21 2.57 2.20 3.70 
Lysolecithin 
(2 mg/ml) 47 29.2 15.8 17.5 
Triton X-100 
(1%) 91 27.6 35.1 5.08 
Aliquots of M1 cells homogenate were incubated 10 min at 0°C with lysolecithin 
(2 mg/ml) or Triton (1%). The mixtures were then centrifuged at 100 000 X g 
for 1 h at 4°C. The supernatant s (soluble fractions) were analysed irectly and the 
pellets were resuspended in the same volume of Tris 10 raM, pH 7.5 (particulate 
fraction). Specific activities of guanylate cyclase are expressed as pmoles cGMP 
formed/min/mg protein. 
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Table 5 
Effect of lysolecithin on the kinetic parameters of 
guanylate cyclase of M1 neuroblastoma cells 
Control Lysolecithin 
K m (mM) 1.56 0.31 
V (pmoles/min/mg protein.) 66 125 
M1 cells homogenate was preincubated with lysolecithin 
(2 mg/ml) as described in methods. Guanylate cyclase acti- 
vity was determined with various concentrations of GTP 
(0.025-1.6 mM). Mu 2÷ concentration was always 7.7 mM. 
Taking in account a possible activity of phospho- 
lipase A in vivo~ producing lysolecithin, we tested the 
effect of treatment with this enzyme on M1 cells 
homogenate; a 100% increase of guanylate cyclase 
activity was observed in this condition (table 6). 
4. Discussion 
The effect of lysolecithin on the enzymic forma- 
tion and degradation of cyclic GMP and cyclic AMP in 
neuroblastoma cells was examined. Guanylate cyclase 
was stimulated and adenylate cyclase inhibited by the 
same concentrations of lysolecithin. Therefore, our 
data are in agreement with the Yin Yang hypothesis of 
Goldberg [16] implying an antagonistic regulation of 
cyclic AMP and cyclic GMP in cellular systems. The 
fact that both cyclase activities were altered by lyso- 
lecithin only and not by lysophosphatidylethanolamine 
indicates that the stimulatory activity on guanylate 
Table 6 
Effect of phospholipase a on guanylate cyclase activity 
pmoles cyclic GMP formed• 
min/mg protein 
Control 1.23 -+ 0.10 
Phospholipase A (1U) 2.50 -+ 0.36 
Phospholipase A (2U) 2.78 -+ 0.12 
Aliquots of M1 cell homogenate were incubated with phos- 
pholipase A as described in Materials and methods. Control 
values were done in the same conditions with boiled phospho- 
lipase A. Each value represents he mean -+ S.D. of 4 deter- 
minations. 
cyclase and the inhibitory activity on adenylate cyclase 
could be related to the choline moiety of the molecule. 
The effect of lysolecithin on guanylate cyclase involved 
substrate affinity as well as 1I. The effects were observ- 
ed under non-stimulated a enylate cyclase conditions, 
but nevertheless can be compared to some extent o 
the results obtained by Shier et al. [17]. These authors 
recently reported a stimulation of guanylate cyclase 
activity by lysolecithin in 3T3 mouse fibroblasts. In 
that system, only fluoride-stimulated by not unstimu- 
lated adenylate cyclase was inhibited by lysolecithin. 
The effect of lysolecithin was found not to be identical 
to that of Triton X-100. Solubilization of guanylate 
cyclase activity was much lower when lysolecithin was 
used. It is probable that, in addition to its detergent 
effect similar to that of Triton, lysolecithin may play 
a specific regulatory rote. The fact that phospholipase A 
also induces a stimuation of guanylate cyclase further 
supports this hypothesis. It might act by generating 
lysolecithin which in turn may serve as a transducer 
altering the general properties of the membrane and 
play a role in the regulation of cellular metabolism in
neuroblastoma cells. 
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